Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 2

Investigation of Cytomegalovirus in Intestinal Tissue in a Country With High CMV Seroprevalence

Pages
123–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compared to tissue IHC staining, the sensitivity of tissue and blood CMV PCR was low while their specificity was higher.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: In Turkey, cytomegalovirus (CMV) seropositivity has been reported to be high, between 85 and 100%.
📊
Key Findings & Data:Patients (≥18 years old, n = 189) who had a colonoscopic biopsy between January and May 2017 were included in the study at our hospital.
💡
Conclusion & Impact:Compared to tissue IHC staining, the sensitivity of tissue and blood CMV PCR was low while their specificity was higher.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Özet

Background: In Turkey, cytomegalovirus (CMV) seropositivity has been reported to be high, between 85 and 100%. CMV has been responsible for disease exacerbation in inflammatory bowel disease (IBD). We aimed to evaluate the presence of CMV in intestinal tissue by immunohistochemical staining in IBD and non-IBD patient groups, in a country with high CMV seroprevalence. Methods: In this prospective cross-sectional study, the presence of intestinal CMV was investigated with tissue immunohistochemistry (IHC) staining, which is accepted as the gold standard method, and with polymerase chain reaction (PCR) in tissue and blood. Patients (≥18 years old, n = 189) who had a colonoscopic biopsy between January and May 2017 were included in the study at our hospital. Clinical, laboratory, endoscopic, and histopathological data of patients were assessed by dividing them into IBD (n = 34) and non-IBD (n = 155) groups. Results: In this study, 567 colonic biopsy samples from 189 patients were evaluated. Tissue IHC staining was positive for 3 (1.58%) non- IBD patients. One of them was diagnosed as CMV ileitis. CMV DNA was also detected in 14 plasma (7.40%, <80-469 copies/mL) and 20 tissue samples (10.69%, 7-15 289 copies/mL). Tissue IHC staining is accepted as the gold standard for CMV ileitis, and the sensitivity and specificity of tissue PCR was 33% and 89.67%, while the sensitivity and specificity of plasma PCR was 66.66% and 93.54%, respectively. Conclusion: Although CMV seroprevalence is high in Turkey, CMV ileitis was diagnosed in only one non-IBD patient (0.53%). Compared to tissue IHC staining, the sensitivity of tissue and blood CMV PCR was low while their specificity was higher.

🔖

Cite This Article

KONYA, H. H., OĞUZ, V. A., AKPINAR, H., SAGOL, Ö., SAYINER, A. A. (2021). Investigation of Cytomegalovirus in Intestinal Tissue in a Country With High CMV Seroprevalence. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 2, 123–132. https://ajindex.com/articles/408869

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Gilmore RB, Taylor KM, Morrissey CO, Gardiner BJ. Cytomegalovirus in inflammatory bowel disease: a clinical approach. Intern Med J. 2020. [CrossRef] 2. Mourad FH, Hashash JG, Kariyawasam VC, Leong RW. Ulcerative colitis and cytomegalovirus infection: from A to Z. J Crohns Colitis. 2020
  2. 14(8):1162-1171. [CrossRef] 3. EKMUD (Infectious Diseases and Clinical Microbiology Speciality Society of Turkey). CMV diagnosis, treatment consensus report. https://ww w.ekm ud.or g.tr/ files /uplo ads/f iles/ CMV-U zlasi -Rapo ru.pd f. Accessed April 2020. 4. Uyar Y, Balci A, Akcali A, Cabar C. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol. 2008
  3. 31(4):451-455. 5. Shieh AC, Guler E, Tirumani SH, Dumot J, Ramaiya NH. Clinical, imaging, endoscopic findings, and management of patients with CMV colitis: a single-institute experience. Emerg Radiol. 2020
  4. 27(3):277-284. [CrossRef] 6. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008
  5. [CrossRef] 7. Stilwell KT, Estes J, Kurtz MT, et al. CMV Ileitis: to treat or not to treat? Implications of initiating biologic therapy for concurrent Crohn’s disease. Case Rep Gastrointest Med. 2019
  6. 4513795. [CrossRef] 8. Umar S, Clarke K, Bilimoria F, et al. Diagnostic yield from colon biopsies in patients with inflammatory bowel disease and suspected cytomegalovirus infection: is it worth it? Ann Gastroenterol. 2017
  7. 30(4):429-432. [CrossRef] 9. Kredel LI, Mundt P, van Riesen L, et al. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study. Int J Colorectal Dis. 2019
  8. 34(2):229-237. [CrossRef] 10. Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014
  9. [CrossRef] 11. Burston J, van Hal S, Dubedat S, Lee A. Inclusions or bystanders? CMV PCR sensitivity and specificity in tissue samples. J Clin Virol. 2017
  10. [CrossRef] 12. Shah J, Dutta U, Das A, et al. Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: a prospective study. JGH Open. 2020
  11. 4(3):382-386. [CrossRef] 13. Kato K, Cooper M. Small bowel perforation secondary to CMVpositive terminal ileitis postrenal transplant. BMJ Case Rep. 2019
  12. 12(11):e231662. [CrossRef] 14. Navaneethan U, Venkatesh PG, Wang J. Cytomega